Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma
2022 · Cancer Cell · 157 citations
https://doi.org/10.1016/j.ccell.2022.12.004
Y
Yanfeng Xi
Henan University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
171
Papers
2.2K
Citations
23
h-index
37
i10-index
Yanfeng Xi is an academic researcher from Henan University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & Cutaneous Melanoma Detection and Management. The author has an h-index of 23, co-authored 146 publications.
ORCID: 0000-0003-0180-8610Papers by this author
worksWhole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma
2016 · The American Journal of Human Genetics · 144 citations
https://doi.org/10.1016/j.ajhg.2015.12.013
INPP4B is an oncogenic regulator in human colon cancer
2015 · Oncogene · 65 citations
https://doi.org/10.1038/onc.2015.361
Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma
2020 · The American Journal of Human Genetics · 11 citations
https://doi.org/10.1016/j.ajhg.2020.07.008
The age variation of HER2 immunohistochemistry positive rate in biopsy specimens of gastric cancer
2020 · Pathology - Research and Practice · 9 citations
https://doi.org/10.1016/j.prp.2020.152882
Tumor-Infiltrating Lymphocytes Improve Magee Equation–Based Prediction of Pathologic Complete Response in HR-Positive/HER2-Negative Breast Cancer
2022 · American Journal of Clinical Pathology · 6 citations
https://doi.org/10.1093/ajcp/aqac041
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat